Published date: 28 November 2024
Awarded contract - This means that the contract has been awarded to a supplier.
Contract summary
Industry
Pharmaceutical products - 33600000
Location of contract
WA7 2ES
Value of contract
£626,522,476
Procurement reference
CF-2716200D0O000000rwimUAA
Published date
28 November 2024
Closing date
23 April 2024
Closing time
1pm
Contract start date
1 November 2024
Contract end date
31 October 2026
Contract type
Supply contract
Procedure type
Open procedure (above threshold)
Any interested supplier may submit a tender in response to an opportunity notice.
This procedure can be used for procurements above the relevant contract value threshold.
Contract is suitable for SMEs?
Yes
Contract is suitable for VCSEs?
No
Description
Project title: NHS Framework for the supply of Licensed Antiretroviral Therapy (ART) for the treatment of HIV (Lot 1) & For the provision of a service to supply over labelled Pre-Exposure Prophylaxis (PrEP) and Post-Exposure Prophylaxis (PEP) Packs for the prevention of HIV (Lot 2) 1st November 2024
Offer reference number: CM/PHS/24/5709
Period of framework agreement: 1st November 2024 to 31st October 2026 with an option to extend (at the Authority's discretion) for a further period (or periods) up to a total of 24 months.
More information
Attachments
-
- Transparency - Framework Agreement v1.docx
- Transparency - Framework Agreement v1
-
- CM_PHS_24_5709_01_MYL (Lot 1).pdf
- CM_PHS_24_5709_01_MYL (Lot 1)
-
- CM_PHS_24_5709_01_NEX (Lot 1).pdf
- CM_PHS_24_5709_01_NEX (Lot 1)
-
- CM_PHS_24_5709_01_MUK (Lot 1).pdf
- CM_PHS_24_5709_01_MUK (Lot 1)
-
- CM_PHS_24_5709_01_MAW (Lot 2).pdf
- CM_PHS_24_5709_01_MAW (Lot 2)
-
- CM_PHS_24_5709_01_LUP (Lot 1).pdf
- CM_PHS_24_5709_01_LUP (Lot 1)
-
- CM_PHS_24_5709_01_MAC (Lot 1).pdf
- CM_PHS_24_5709_01_MAC (Lot 1)
-
- CM_PHS_24_5709_01_RED (Lot 1).pdf
- CM_PHS_24_5709_01_RED (Lot 1)
-
- CM_PHS_24_5709_01_AMA (Lot 1).pdf
- CM_PHS_24_5709_01_AMA (Lot 1)
-
- CM_PHS_24_5709_01_MIL (Lot 1).pdf
- CM_PHS_24_5709_01_MIL (Lot 1)
-
- CM_PHS_24_5709_01_VIV (Lot 1).pdf
- CM_PHS_24_5709_01_VIV (Lot 1)
-
- CM_PHS_24_5709_01_MLE (Lot 1).pdf
- CM_PHS_24_5709_01_MLE (Lot 1)
-
- CM_PHS_24_5709_01_JAN (Lot 1).pdf
- CM_PHS_24_5709_01_JAN (Lot 1)
-
- CM_PHS_24_5709_01_ABV (Lot 1).pdf
- CM_PHS_24_5709_01_ABV (Lot 1)
Award information
Awarded date
28 October 2024
Contract start date
1 November 2024
Contract end date
31 October 2026
Total value of contract
£626,522,476
This contract was awarded to 13 suppliers.
Gilead Sciences Limited
Address
280 High Holborn, WC1V 7EE
Reference
None
ViiV Healthcare UK Ltd
Address
79 New Oxford Street, London,, WC1A 1DG
Reference
None
Merck Sharpe & Dohme (UK) Limited
Address
120 Moorgate, EC2M 6UR
Reference
None
Mawdsley-Brooks & Co Ltd
Address
Number Three, South Langworthy, Road, PO BOX 18, Salford, M50 2PW
Reference
None
Abbvie Ltd
Address
Abbvie House, Vanwall Business Park, Vanwall Road, Maidenhead Berks, SL6 4UB
Reference
None
Janssen-Cilag Ltd
Address
Janssen-Cilag Ltd, 50-100 Holmers Farm Way, High Wycombe,, HP12 4DP
Reference
None
Lupin Healthcare (UK) Limited
Address
The Urban Building 3-9 Albert Street Slough, SL1 2BE
Reference
None
Dr.Reddy's Laboratories (UK) Limited
Address
6 Riverview Road, Beverley
Reference
None
Macleods Pharma UK Limited
Address
Wynyard Park House, Wynyard Avenue, Billingham, TS22 5TB
Reference
None
Mylan
Address
Building 4, Trident Place Mosquito Way Hatfield Hertfordshire, AL10 9UL
Reference
None
MSN Laboratories Europe Limited
Address
Devonshire Business Centre, Works Road, Letchworth, SG6 1GJ
Reference
None
Amarox Limited
Address
Congress House, 14 Lyon Road, Harrow Middlesex, HA1 2EN
Reference
None
Milpharm Ltd/aurobinbdo Primary
Address
Ares Block, Odyssey Business Park, South Ruislip, HA4 6QD
Reference
None
About the buyer
Contact name
Michelle Clarke
Address
2nd Floor
Runcorn
WA7 2ES
United Kingdom
Share this notice
Closing: 23 April 2024, 1pm
All content is available under the
